MIM
CBAY

Macroview Investment Management’s Cymabay Therapeutics CBAY Stock Holding History

Macroview Investment Management’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1
Closed -$24 – 716
2023
Q4 		$24 Hold
1
– – ﹤0.01% 617
2023
Q3 		$15 Hold
1
– – ﹤0.01% 797
2023
Q2 		$11 Hold
1
– – ﹤0.01% 497
2023
Q1 		$9 Hold
1
– – ﹤0.01% 450
2022
Q4 		$6 Hold
1
– – ﹤0.01% 458
2022
Q3 		$0 Buy
+1
New +$4 ﹤0.01% 544

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Macroview Investment Management's CBAY Position: Q1 2024 in Review

Macroview Investment Management sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 1 share — an estimated $24 sold.

Macroview Investment Management first reported a position in CBAY in Q3 2022 and held it in 6 quarters. The position peaked at $24 in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • Macroview Investment Management reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Macroview Investment Management sold 1 Cymabay Therapeutics share in Q1 2024, an estimated $24.
  • Macroview Investment Management first reported a position in Cymabay Therapeutics in Q3 2022 and held it in 6 quarters.
  • Macroview Investment Management's Cymabay Therapeutics position peaked at $24 in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Macroview Investment Management's 13F filing for Q1 2024, filed 30 Apr 2024.